ARTICLE | Company News
Layton, Targacept deal
September 3, 2002 7:00 AM UTC
Targacept acquired Layton's Inversine mecamylamine nicotinic acetylcholine receptor antagonist, which is marketed to treat hypertension. Targacept also received exclusive rights to IP from the Unive...